NAYA
Price
$2.05
Change
+$0.05 (+2.50%)
Updated
Apr 1, 04:57 PM (EDT)
Capitalization
1.18M
VNDA
Price
$4.50
Change
-$0.09 (-1.96%)
Updated
Apr 1 closing price
Capitalization
262.42M
28 days until earnings call
Ad is loading...

NAYA vs VNDA

Header iconNAYA vs VNDA Comparison
Open Charts NAYA vs VNDABanner chart's image
NAYA Biosciences
Price$2.05
Change+$0.05 (+2.50%)
Volume$200
Capitalization1.18M
Vanda Pharmaceuticals
Price$4.50
Change-$0.09 (-1.96%)
Volume$885.61K
Capitalization262.42M
NAYA vs VNDA Comparison Chart
Loading...
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAYA vs. VNDA commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAYA is a Hold and VNDA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (NAYA: $2.00 vs. VNDA: $4.50)
Brand notoriety: NAYA and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAYA: 51% vs. VNDA: 135%
Market capitalization -- NAYA: $1.18M vs. VNDA: $262.42M
NAYA [@Biotechnology] is valued at $1.18M. VNDA’s [@Biotechnology] market capitalization is $262.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAYA’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • NAYA’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both NAYA and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAYA’s TA Score shows that 5 TA indicator(s) are bullish while VNDA’s TA Score has 5 bullish TA indicator(s).

  • NAYA’s TA Score: 5 bullish, 3 bearish.
  • VNDA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NAYA is a better buy in the short-term than VNDA.

Price Growth

NAYA (@Biotechnology) experienced а -17.01% price change this week, while VNDA (@Biotechnology) price change was -6.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

VNDA is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($262M) has a higher market cap than NAYA($1.18M). VNDA has higher P/E ratio than NAYA: VNDA (126.00) vs NAYA (1.30). VNDA YTD gains are higher at: -6.054 vs. NAYA (-79.424). NAYA has higher annual earnings (EBITDA): -5.58M vs. VNDA (-32.53M). VNDA has more cash in the bank: 375M vs. NAYA (472K). NAYA has less debt than VNDA: NAYA (5.34M) vs VNDA (12.4M). VNDA has higher revenues than NAYA: VNDA (199M) vs NAYA (6.23M).
NAYAVNDANAYA / VNDA
Capitalization1.18M262M0%
EBITDA-5.58M-32.53M17%
Gain YTD-79.424-6.0541,312%
P/E Ratio1.30126.001%
Revenue6.23M199M3%
Total Cash472K375M0%
Total Debt5.34M12.4M43%
FUNDAMENTALS RATINGS
NAYA vs VNDA: Fundamental Ratings
NAYA
VNDA
OUTLOOK RATING
1..100
7860
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
9852
P/E GROWTH RATING
1..100
362
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAYA's Valuation (57) in the null industry is in the same range as VNDA (84) in the Biotechnology industry. This means that NAYA’s stock grew similarly to VNDA’s over the last 12 months.

NAYA's Profit vs Risk Rating (100) in the null industry is in the same range as VNDA (100) in the Biotechnology industry. This means that NAYA’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (91) in the Biotechnology industry is in the same range as NAYA (100) in the null industry. This means that VNDA’s stock grew similarly to NAYA’s over the last 12 months.

VNDA's Price Growth Rating (52) in the Biotechnology industry is somewhat better than the same rating for NAYA (98) in the null industry. This means that VNDA’s stock grew somewhat faster than NAYA’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for NAYA (36) in the null industry. This means that VNDA’s stock grew somewhat faster than NAYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAYAVNDA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 16 days ago
70%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FISGX35.76N/A
N/A
Nuveen Small/Mid Cap Growth Opp I
CNZLX10.34N/A
N/A
Commonwealth Australia/New Zealand
VSPVX403.73N/A
N/A
Vanguard S&P 500 Value Index Instl
MMMPX21.67N/A
N/A
Morgan Stanley Inst Emerging Mkts R6
ASYLX14.79N/A
N/A
AB Select US Long/Short Advisor

NAYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAYA has been loosely correlated with VNDA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NAYA jumps, then VNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAYA
1D Price
Change %
NAYA100%
N/A
VNDA - NAYA
36%
Loosely correlated
-2.13%
RANI - NAYA
27%
Poorly correlated
-7.35%
KPTI - NAYA
27%
Poorly correlated
-10.10%
SSKN - NAYA
25%
Poorly correlated
-1.86%
PEN - NAYA
24%
Poorly correlated
-0.06%
More